MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
2 hedge funds and large institutions have $6.87M invested in MetLife Inc 5.625% Series E Preferred Stock in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
0.02% more ownership
Funds ownership: 0.86% → 0.89% (+0.02%)
0% more funds holding
Funds holding: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $6.94M → $6.87M (-$68.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$185K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$4.24K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CGH
1
Crossmark Global Holdings
Houston,
Texas
| $6.85M | +$185K | +7,570 | +3% |
|
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $23.1K | +$4.24K | +173 | +23% |
|
MET.PRE Hedge Fund Activity: Q2 2023 in Review
2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q2 2023, worth a combined $6.87M — down 0.99% from $6.94M a quarter earlier.
Fund positioning in MET.PRE was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Crossmark Global Holdings, adding an estimated $185K.
- 2 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $6.87M of MetLife Inc 5.625% Series E Preferred Stock stock for Q2 2023, down 0.99% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q2 2023 and 0 closed out.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q2 2023 was Crossmark Global Holdings, an estimated $185K added.
Based on aggregated 13F filings for Q2 2023.